NEW ORLEANS, LA—Ever since statin guidelines were revised to urge physicians to prescribe high-intensity statins rather than treating to a specific LDL target, the debate has continued: is the “fire ...

Compared with high-intensity statin therapy, moderate intensity statin therapy plus ezetimibe was equally effective in preventing CV events among patients undergoing PCI. Moderate-intensity statin ...

Email reminders to physicians about proper dosing of high-intensity statins, individualized to specific patients and often timed around their appointments, significantly improved the likelihood of ...

Among patients with atherosclerotic cardiovascular disease (ASCVD), high-intensity statins are underutilized in routine care, according to a study published online Aug. 2 in Circulation: ...

Please provide your email address to receive an email when new articles are posted on . A treat-to-target statin strategy was noninferior to a high-intensity statin strategy in CAD. The data highlight ...

In a recent study published in JAMA, researchers investigated whether treat-to-target (TTT) low-density lipoprotein-cholesterol (LDL-C) therapy was inferior to administering statins of high intensity ...

Please provide your email address to receive an email when new articles are posted on . High-intensity statin therapy may increase bleeding risk after minor stroke. Statin dose, moderate or high, did ...

If your doctor has ever told you to "keep an eye on your numbers," here's good news: The rules around what’s considered high cholesterol have gotten clearer—and a little more personal. In March, the ...

Share on Pinterest There is no reason for statin users to avoid exercise, as long as it is of moderate intensity, a new study finds. Image credit: Jessie Casson/Getty Images. A new study found that ...

Zocor (simvastatin) and Lipitor (atorvastatin) are both statin drugs, which are medications used to lower cholesterol levels in the blood. Statins primarily work by inhibiting the enzyme HMG-CoA ...

The combination of ezetimibe and a moderate-intensity statin after coronary stenting may be safer and more clinically effective than monotherapy with a high-intensity statin, suggests a "real-world" ...